Investigating Biomarkers of Treatment Resistance in Human Papillomavirus-Related Head and Neck Cancer
研究人乳头瘤病毒相关头颈癌治疗耐药性的生物标志物
基本信息
- 批准号:466984
- 负责人:
- 金额:$ 1.27万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Studentship Programs
- 财政年份:2021
- 资助国家:加拿大
- 起止时间:2021-12-01 至 2022-12-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Head and neck cancer is the 6th most common cancer in the world. It typically arises in the lining of the mouth, neck, and throat and is collectively referred to as head and neck squamous cell carcinoma (HNSCC). Recently, infection by the sexually transmi
头颈癌是世界上第六大常见癌症。它通常发生在口腔,颈部和喉咙的衬里,统称为头颈部鳞状细胞癌(HNSCC)。最近,性传播感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dawson Alice A其他文献
Dawson Alice A的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Development of a novel translymphatic chemotherapy using anti-EGFR antibody for metastatic lymph nodes of head and neck cancer
使用抗 EGFR 抗体开发用于头颈癌转移性淋巴结的新型经淋巴化疗
- 批准号:
16K11247 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel lymphatic chemotherapy targeting metastatic lymph nodes in patients with head and neck cancer using anti-cancer drugs combined with micelle
抗癌药物联合胶束针对头颈癌患者转移淋巴结的新型淋巴化疗
- 批准号:
25462693 - 财政年份:2013
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sensitization for chemotherapy and radiation by gene induction which suppresses DNA repair in head and neck cancer
通过抑制头颈癌 DNA 修复的基因诱导对化疗和放疗增敏
- 批准号:
23592544 - 财政年份:2011
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel approach to translymphatic chemotherapy targeting sentinel lymph nodes of patients with head and neck cancer
开发针对头颈癌患者前哨淋巴结的经淋巴化疗新方法
- 批准号:
22591920 - 财政年份:2010
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Is the improvement in survival for HPV associated head and neck cancer due to the addition of chemotherapy to radiotherapy or to a more treatment-sensitive cancer?
HPV 相关头颈癌生存率的改善是由于在放疗中添加化疗还是由于对治疗更敏感的癌症?
- 批准号:
211465 - 财政年份:2010
- 资助金额:
$ 1.27万 - 项目类别:
Operating Grants
Is the improvement in survival for HPV associated head and neck cancer due to the addition of chemotherapy to radiotherapy or to a more treatment-sensitive cancer?
HPV 相关头颈癌生存率的改善是由于在放疗中添加化疗还是由于对治疗更敏感的癌症?
- 批准号:
199318 - 财政年份:2009
- 资助金额:
$ 1.27万 - 项目类别:
Operating Grants
Customizing Adjuvant Chemotherapy in Head and Neck Cancer
头颈癌的定制辅助化疗
- 批准号:
19791222 - 财政年份:2007
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of a novel combined chemotherapy in head and neck cancer-combination of a DNA demethylating agent and an anticancer agent-
开发头颈癌新型联合化疗——DNA去甲基化剂和抗癌剂的组合——
- 批准号:
15390617 - 财政年份:2003
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular targets of 5FU and combined chemotherapy of 5FU plus low dose CDDP for head and neck cancer
5FU和5FU加低剂量CDDP联合化疗治疗头颈癌的分子靶点
- 批准号:
13671812 - 财政年份:2001
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic study on chemotherapy combined with gene transfection for head and neck cancer
化疗联合基因转染治疗头颈癌的基础研究
- 批准号:
10470354 - 财政年份:1998
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (B).














{{item.name}}会员




